In early 2020, we all became aware of a new pandemic, COVID-19.

​

It quickly became apparent that in some patients the virus was associated with a severe coagulopathy, resulting in significant morbidity and mortality.

​

Our understanding of the pathophysiology and management is rapidly evolving.

​

-----

​

Presentation: Alfred Lee​, MD, PhD, Yale

Date: January 28, 2021